Turkey Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
Summary
Generics in Turkey industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Turkish generics market had total revenues of $2.4bn in 2021, representing a compound annual growth rate (CAGR) of 29% between 2016 and 2021.
- Market consumption volume increased with a CAGR of 1.5% between 2016 and 2021, to reach a total of 62.4 % in 2021.
- Over the past five years, the Turkish market recorded growth of 27.2%. Growth in the market has been driven by demographic trends alongside strong supply-side infrastructure.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Turkey
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Turkey
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Turkey generics market with five year forecasts by both value and volume
- What was the size of the Turkey generics market by value in 2021?
- What will be the size of the Turkey generics market in 2026?
- What factors are affecting the strength of competition in the Turkey generics market?
- How has the market performed over the last five years?
- What are the main segments that make up Turkey's generics market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive Landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths/weaknesses of the leading players?
- 7.3. Has there been any significant recent M&A activity?
- 7.4. How did the COVID-19 pandemic impact leading players?
- 8 Company Profiles
- 8.1. Deva Holding AS
- 8.2. Pfizer Inc.
- 8.3. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
- 8.4. Nobelpharma Co Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Turkey generics market value: $ million, 2016-21
- Table 2: Turkey generics market volume: %, 2016-21
- Table 3: Turkey generics market geography segmentation: $ million, 2021
- Table 4: Turkey generics market value forecast: $ million, 2021-26
- Table 5: Turkey generics market volume forecast: %, 2021-26
- Table 6: Deva Holding AS: key facts
- Table 7: Deva Holding AS: Annual Financial Ratios
- Table 8: Deva Holding AS: Key Employees
- Table 9: Pfizer Inc.: key facts
- Table 10: Pfizer Inc.: Annual Financial Ratios
- Table 11: Pfizer Inc.: Key Employees
- Table 12: Pfizer Inc.: Key Employees Continued
- Table 13: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: key facts
- Table 14: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees
- Table 15: Nobelpharma Co Ltd: key facts
- Table 16: Nobelpharma Co Ltd: Key Employees
- Table 17: Nobelpharma Co Ltd: Key Employees Continued
- Table 18: Turkey size of population (million), 2017-21
- Table 19: Turkey gdp (constant 2005 prices, $ billion), 2017-21
- Table 20: Turkey gdp (current prices, $ billion), 2017-21
- Table 21: Turkey inflation, 2017-21
- Table 22: Turkey consumer price index (absolute), 2017-21
- Table 23: Turkey exchange rate, 2017-21
- List of Figures
- Figure 1: Turkey generics market value: $ million, 2016-21
- Figure 2: Turkey generics market volume: %, 2016-21
- Figure 3: Turkey generics market geography segmentation: % share, by value, 2021
- Figure 4: Turkey generics market value forecast: $ million, 2021-26
- Figure 5: Turkey generics market volume forecast: %, 2021-26
- Figure 6: Forces driving competition in the generics market in Turkey, 2021
- Figure 7: Drivers of buyer power in the generics market in Turkey, 2021
- Figure 8: Drivers of supplier power in the generics market in Turkey, 2021
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in Turkey, 2021
- Figure 10: Factors influencing the threat of substitutes in the generics market in Turkey, 2021
- Figure 11: Drivers of degree of rivalry in the generics market in Turkey, 2021
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook